The Biologic Shift (ODT Mag by Sean Fenske)
While I’ve touched on the growing field of biologics within the orthopedic industry (most recently observed during my trip to the NASS annual meeting in Boston last year), I haven’t had too many opportunities to speak with the providers of these innovative offerings. As such, while attending the NASS event, I was sure to meet up with a representative from Bioventus—a company that provides these more natural-based alternatives exclusively.
Although I’ve spoken with Bioventus in the past, this was my first introduction to the Surgical division. To address the questions I had regarding this division and its offerings for the spinal sector, Steven Moore, a senior product manager with Bioventus Surgical, was kind enough to take time out to address my queries. In this interview, Moore shares his insights on the company, the biologics offerings, and what he expects in the near future.
Sean Fenske: Can you please provide a bit of background information on Bioventus?
Steven Moore: Bioventus was established in 2012, spun out of the biologics division of Smith & Nephew. The company is privately held and headquartered in Durham, N.C., with its i...
